Source: Idifarma Blog

Idifarma Blog Idifarma renews French Crdit d'impt recherche (CIR)

Idifarma has renewed the approval by the French Ministry as an outsourcing partner for R&D activities under the conditions of the Crédit d'Impôt Recherche (CIR). La entrada Idifarma renews French Crédit d'impôt recherche (CIR) se publicó primero en Idifarma.

Read full article »

Idifarma's Competitors | Idifarma's News | Idifarma's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

100-250

General Manager

Luis Oquinena

CEO Approval Rating

89/100

Idifarma is a Spain-based CDMO that provides services including GMP manufacturing, quality control, formulation and analytical development for the pharmaceutical sector.

Idifarma Blog Idifarma renews French Crdit d'impt recherche (CIR)

Idifarma has renewed the approval by the French Ministry as an outsourcing partner for R&D activities under the conditions of the Cr&eacute;dit d'Impôt Recherche (CIR). La entrada Idifarma renews French Cr&eacute;dit d'impôt recherche (CIR) se public&oacute; primero en Idifarma.

Followers on Owler

Idifarma has renewed the approval by the French Ministry as an outsourcing partner for R&D activities under the conditions of the Crédit d'Impôt Recherche (CIR). La entrada Idifarma renews French Crédit d'impôt recherche (CIR) se publicó primero en Idifarma.